Dr. Prameela Banoth, MD

Dr. Banoth practices at Nottingham Dialysis in Kansas City, Missouri.

Dr. Banoth's NPI, 1720395171, was assigned on September 7, 2010. Dr. Banoth holds Missouri license 2012019401.

Dr. Banoth's primary practice is Nottingham Dialysis, at 2790 Clay Edwards Dr, Kansas City, MO 64116 in Clay County. The practice phone is (913) 764-0358.

Dr. Banoth's primary practice is Nottingham Dialysis in Kansas City, Missouri. Dr. Banoth is also affiliated with The University of Kansas Hospital. The medical group on file is University Health Physicians. Dmand AI also links Dr. Banoth to 5 more hospitals, 3 dialysis centers, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Banoth practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Banoth's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Banoth's licenses on file in 2 states: Missouri and Illinois.

CMS data shows 559 Medicare services from Dr. Banoth across 7 procedure codes in 2024, for 153 Medicare patients. Medicare paid $84,221 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 153 Medicare patients who saw Dr. Banoth in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have chronic kidney disease, and 75% have diabetes. 87% are also on Medicaid. Their average risk score is 7.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Banoth's median patient age at 69, with 48% women.

In 2024, Dr. Banoth wrote 1,670 Medicare Part D claims for 144 patients. 88% of them were for generic drugs. CMS names the drug for 1,512 of them, across 37 drugs with 11 or more claims each, at $159,419 in total drug cost. In 2023, CMS named 388 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 61 out of 100 for Dr. Banoth for performance year 2024, reported as part of a group. Dr. Banoth accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 51 general payments to Dr. Banoth from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. Fresenius USA Marketing, Inc. paid the most, $1,524.